|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: HEMISPHERX BIOPHARMA INC, 10-K/A, 2000-08-11 |
Next: KLAMATH FIRST BANCORP INC, 10-Q, 2000-08-11 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-END> DEC-31-1999
<CASH> 6,396,423
<SECURITIES> 2,152,966
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 11,017,689
<PP&E> 1,103,408
<DEPRECIATION> 770,048
<TOTAL-ASSETS> 14,167,740
<CURRENT-LIABILITIES> 1,510,876
<BONDS> 0
0
0
<COMMON> 27,975
<OTHER-SE> 12,628,889
<TOTAL-LIABILITY-AND-EQUITY> 12,656,864
<SALES> 0
<TOTAL-REVENUES> 1,160,351
<CGS> 0
<TOTAL-COSTS> 10,361,578
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> (9,201,227)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (9,201,227)
<EPS-BASIC> (.35)
<EPS-DILUTED> (.35)
</TABLE>
|
|